New advances in ovulation induction

Current Opinion in Obstetrics and Gynecology

Volumn 19, Issue 3, 2007, Pages 248-252

  Kafy, Souzan ^a   Tulandi, Togas ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Aromatase inhibitors; Clomiphene citrate; Gonadotropin; Laparoscopic ovarian drilling; Ovulation induction; Tamoxifen

Indexed keywords

ANASTROZOLE; CLOMIFENE CITRATE; DEXAMETHASONE; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; METFORMIN; RECOMBINANT FOLLITROPIN; TAMOXIFEN;

AORTA STENOSIS; BONE MALFORMATION; CAUTERIZATION; DRILL; FEMALE INFERTILITY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LAPAROSCOPIC SURGERY; LOW DRUG DOSE; MULTIPLE PREGNANCY; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SUPEROVULATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AROMATASE INHIBITORS; CLOMIPHENE; ESTROGEN ANTAGONISTS; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; NITRILES; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; TAMOXIFEN; TREATMENT OUTCOME; TRIAZOLES;

EID: 34248337041     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3280c60c9a     Document Type: Review

References (26)

1. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril 2006; 85:277-284. This is a systematic review of aromatase inhibitors. The authors concluded that aromatase inhibitors offer a better alternative to clomiphene citrate for ovulation induction and superovulation.
2. Elnashar A, Abdelmageed E, Fayed M, Sharaf M. Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod 2006; 21:1805-1808.
3. Felemban A, Tan SL, Tulandi T. Laparoscopic treatment of polycystic ovaries with insulated needle cautery. Fertil Steril 2000; 73:266-269.
4. Saleh AM, Khalil HS. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2004; 83:614-621.
5. Zhu W, Li X, Chen X, et al. Ovarian interstitial YAG-laser: an effective new method to manage anovulation in women with polycystic ovary syndrome. Am J Obstet Gynecol 2006; 195:458-463.
6. Palomba S, Falbo T, Orio F Jr, et al. Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age. Gynecol Endocrinol 2006; 22:329-335.
7. Nestler JE. Is metformin or clomiphene citrate more effective for ovulation induction in polycystic ovary syndrome? Nat Clin Pract Endocrinol Metab 2006; 2:128-129.
8. Platteau P, Andersen AN, Balen A, et al., Menopur Ovulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod 2006; 21:1798-1804. In this randomized study, the effectiveness of HP-hMG and rFSH in anovulatory World Health Organization Group II women appears to be similar; however, the rate of ovarian hyperstimulation syndrome and/or cancellation due to excessive response in the rFSH group was 9.8% and in the HP-hMG group was 2.2%.
9. Al-Fadhli R, Sylvestre C, Buckett W, et al. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 2006; 85:161-164. This was a prospective randomized trial showing that the ideal dose of letrozole appears to be 5mg daily for 5 days.
10. Jee BC, Ku SY, Suh CS, et al. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril 2006; 85:1774-1777.
11. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192:381-386.
12. Bayar U, Tanriverdi HA, Barut A, et al. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril 2006; 85:1045-1048.
13. Elnashar A, Fouad H, Eldosoky M, Saeid N. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio. Fertil Steril 2006; 85:511-513.
14. Sohrabvand F, Ansari S, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomipheneresistant infertile women with polycystic ovarian disease. Hum Reprod 2006; 21:1432-1435.
15. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005; 84:S95.
16. Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006; 85:1761-1765. This is an important study disputing the results of an abstract presentation that letrozole treatment is associated with cardiac and bone malformation [15]. The concern that letrozole use for ovulation induction could be teratogenic is unfounded based on these results.
17. Al-Omari WR, Sulaiman WR, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2004; 85:289-291.
18. Shokeir TA. Tamoxifen citrate for women with unexplained infertility. Arch Gynecol Obstet 2006; 274:279-283.
19. Nardo LG. Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate. Gynecol Endocrinol 2004; 19:235-238.
20. Steiner AZ, Terplan M, Paulson RJ. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod 2005; 20:1511-1515.
21. Sammour A, Biljan M, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Fertil Steril 2001; 76:S110.
22. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75:305-309.
23. Mitwally MF, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2002; 78:S277-S278.
24. Healey S, Tan SL, Tulandi T, Biljan M. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2003; 80:1325-1329.
25. Biljan M, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of 2.5 and 5.0mg of letrozole (LE) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation. Fertil Steril 2002; 78:S55.
26. Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004; 82:1561-1563.